Skip to main content

Iradimed Corp

IRMD
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001325618

In the last 90 days, Iradimed Corp insiders filed 0 open-market purchases and 1 sale; 213 institutions reported holding it in 13F filings for Q2 2026, worth $750.2M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Iradimed Corp changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of IRMD: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders168162−6
Shares6.96M7.05M+90.1K (+1.3%)
Value$365.3M$421.6M+$56.3M (+15.4%)

New holders (14)

Institutions that held Iradimed Corp at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to IRMD in Q2 2025
InstitutionSharesValue% of portfolio
Johnson Investment Counsel Inc25,655$1.53M0.01%
Polen Capital Management LLC24,889$1.49M0.00%
Quadrature Capital Ltd4,436$265.2K0.00%
Brevan Howard Capital Management LP4,348$260.0K0.00%
Prudential Financial Inc4,010$239.8K0.00%
Price T Rowe Associates Inc3,848$231.0K0.00%
Citadel Advisors LLC3,407$203.7K0.00%
Virtus ETF Advisers LLC1,650$98.7K0.06%
Spire Wealth Management1,000$59.8K0.00%
Parkside Financial Bank & Trust190$11.4K0.00%
Essential Partners LLC18$1.08K0.00%
DecisionPoint Financial, LLC9$5450.00%
Allworth Financial LP1$600.00%
Aquatic Capital Management LLC1$600.00%

Sold out (20)

Institutions that held Iradimed Corp at the end of Q1 2025 and filed for Q2 2025 without it.